Table 3.
Monophasic TM | NMOSD | |
---|---|---|
Total population prevalence | 1.00 | 0.34 |
Adult prevalence in total population (aged ≥20 years) | 1.00 | 0.39 |
Adult prevalence in Emirati population (aged ≥20 years) | 2.46 | 1.76 |
Adult incidence in Emirati population (aged ≥20 years) | 0.57 | 0.17 |
NMOSD, neuromyelitis optica spectrum disorders; TM, transverse myelitis.